POPULARITY
Send us a textIn this exclusive fireside chat, Dr. Jacque Sokolov, Chairman and CEO of SSB, shares his journey through 30+ years of healthcare innovation, investment, and entrepreneurship. With multiple billion-dollar exits, including a Decacorn, and managing one of the largest LLCs with over 1,000 investors, Dr. Sokolov offers invaluable lessons on scaling businesses, identifying healthcare opportunities, and navigating complex markets.Key highlights include:- The $5 trillion U.S. healthcare market's untapped potential.- Opportunities in physician practice management, mRNA, DNA, and AI-enabled applications.- Building strategic partnerships for growth.- Advice for founders and investors seeking 10x to 30x returns.Don't miss this deep dive into healthcare and life sciences with one of the industry's most accomplished leaders.
Explore the recent updates in U.S. AI laws, focusing on regulations specific to the health and life sciences sector. With the rise of state-level AI legislation, particularly in California, this episode of AI Issue Spotting discusses how these new laws are shaping the regulatory landscape particularly for entities in the health and life sciences sector. Unlike broad, EU-style regulations, these laws are tailored to address sector-specific challenges and use cases, signaling a continued trend of fragmented, patchwork regulations across industries. Scott Loughlin is joined by Hogan Lovells colleagues Jessica Robinson Hanna and Alyssa Golay to examine the implications of these changes for healthcare, data compliance, and AI in general.
In this episode of the Life Science Success Podcast, I am interviewing Dr. Stavros Papadopoulos, the founder and CEO of TileDB, Inc. We delve into Dr. Papadopoulos's journey from academia to entrepreneurship, exploring how his experiences at Intel, MIT CSAIL, and in Hong Kong shaped his innovative approach to data management. Dr. Papadopoulos shares insights on TileDB's mission to revolutionize data analytics in life sciences, discussing the unique features of their data management system and how it's addressing critical challenges in genomics and other scientific fields. We also explore the future of big data in life sciences, leadership in tech startups, and Dr. Papadopoulos's personal inspirations and concerns about the industry. 00:00 Introduction to Life Science Success Podcast 00:43 Sponsor Message from D3 Digital Media Marketing 01:19 Interview with Dr. Stavros Papadopoulos Begins 01:51 Dr. Papadopoulos' Background and Journey 02:33 The Birth of TileDB 03:16 Technical Innovations of TileDB 05:27 TileDB's Impact on Life Sciences 09:07 Influence of MIT and Intel on TileDB 10:40 Entrepreneurial Journey and Challenges 14:36 TileDB's Mission and Vision 15:58 Real-World Applications and Collaborations 25:45 Leadership and Business Insights 34:44 Final Thoughts and Reflections 41:37 Conclusion and Podcast Wrap-Up
Join Manasi Patwa (Wharton '25) in her conversation with Shaq Vayda, Principal at Lux Capital. Lux is a leading venture capital firm investing in companies positioned at the cutting edge of advanced technology and has $5B+ in assets under management. In this discussion, Manasi and Shaq dive into key growth vectors within AI-driven biotech, recent developments in drug discovery technology, and shifts in the private markets investing landscape. Shaq also provides valuable insights regarding choosing sectors of focus within investing and what strong sourcing entails.
Welcome to the CanadianSME Small Business Podcast, where we spotlight the issues that matter most to Canadian entrepreneurs. As Black Friday and Cyber Monday approach, the stakes are high for businesses navigating the bustling digital marketplace. While these events present unparalleled opportunities to boost sales, they also open the door to potential cyber threats. Today, we're diving into cybersecurity essentials to ensure safe online shopping experiences and build trust with your customers. Joining us is Anastasia Lou Regen, a Cyber Partner at EY Canada. With expertise in Cybersecurity Transformation and Risk Management across industries like Consumer Products, Retail, and Life Sciences, Anastasia has guided national and multinational clients in developing robust cybersecurity frameworks. Her leadership ensures businesses can capitalize on growth opportunities without compromising security.In this episode, we'll explore:Cyber Threats in Retail: Understanding the risks businesses face during high-traffic shopping events.Building Consumer Trust: Best practices for safeguarding customer data and ensuring secure transactions.Actionable Cyber Tips: Simple yet effective strategies to protect your business during the holiday sales rush.Stay tuned as we uncover how businesses can navigate the holiday sales season with confidence by integrating smart cybersecurity measures.Special thanks to our partners:RBC: https://www.rbcroyalbank.com/dms/business/accounts/beyond-banking/index.htmlUPS: https://solutions.ups.com/ca-beunstoppable.html?WT.mc_id=BUSMEWAConstant Contact: https://www.constantcontact.com/landing1/new-marketer?utm_campaign=canadiansme&utm_medium=sponsorlogo&utm_source=brandIHG Hotels and Resorts: https://businessedge.ihg.com/s/registration?language=en_US&CanSMEGoogle: https://www.google.ca/For more expert insights, subscribe to the CanadianSME Small Business Magazine at www.canadiansme.ca. Join us next time as we continue bringing valuable strategies to help your business grow.
Can the ideological emphasis on Diversity, Equity, and Inclusion (DEI) slow down the progress of science? Our guest today is Anna Krylov, professor of chemistry at the University of Southern California and an advocate for maintaining meritocracy in scientific funding and evaluation. She joins John Tomasi to discuss critical tensions in today's scientific landscape. Krylov addresses the potential social costs of slower scientific progress due to ideological influences, particularly DEI, which she argues undermines public trust in scientific institutions. This episode delves into the fraught terrain of funding in academia and the impact of DEI mandates, examining how these changes may contribute to public mistrust and the erosion of merit-based systems. In This Episode:The effects of DEI mandates on scientific fundingThe importance of merit-based funding in academiaThe rise of "citation justice" and its impact on scholarly recognitionGender quotas and their potential implications for scientific standardsCritical social justice influences on scientific practices Censorship in the Sciences Conference: https://dornsife.usc.edu/cesr/censorship-in-the-sciences-interdisciplinary-perspectives/ About Anna:Anna Krylov is a Professor of Chemistry at USC and a leading figure in theoretical and computational quantum chemistry. Born in Ukraine, she earned her degrees from Moscow State University and the Hebrew University. Krylov's research focuses on methods for electronic excited species and has led to over 300 publications. She has received numerous awards, including the Dirac Medal, and is a Fellow of various scientific societies. An advocate for gender equality in STEM, she also promotes academic freedom and authored the impactful paper "The Peril of Politicizing Science." Follow Heterodox Academy on:Twitter: https://bit.ly/3Fax5DyFacebook: https://bit.ly/3PMYxfwLinkedIn: https://bit.ly/48IYeuJInstagram: https://bit.ly/46HKfUgSubstack: https://bit.ly/48IhjNF
In this episode of Moving Forward, Giving Back, four of our incredible donors and life sciences leaders sit down for a roundtable discussion about their involvement in our program Life Science Shares. This campaign is a way for companies or individual leaders to contribute to Life Science Cares if and when they reach financial milestones or other positive events by pledging a percentage of a future transaction. Joining the discussion are host Jeff Marrazzo, the co-founder and former CEO of Spark Therapeutics, and guests Sarah Boyce, CEO and President of Avidity Bio, Robert Blum, President and CEO of Cytokinetics and Ron Cooper, Chairman of C4 Therapeutics and former CEO of Albireo Pharma. During this dynamic conversation Jeff, Sarah, Robert and Ron explain their reasons for getting involved with the Life Science Shares initiative and the benefits the decision has had for them personally and for their companies. Learn more about LSC and Life Science Shares at lifesciencecares.org.
2024年的年終特輯下集來囉！這次三腳貓們各自準備了一個問題想要問其他三腳貓做靈魂拷問！你的座右銘是什麼？你最喜歡的音樂是什麼？也請聽眾朋友們一起來想想這些問題吧！ 工作人員 內容製作：雯薇、若晴、Angel、天豪、浩文、Mike 後製：雯薇 文案：雯薇 音樂：雯薇 封面：雯薇 上架：雯薇 宣傳：Angel、雯薇 -- Hosting provided by SoundOn
Kartik Sundar is the founder of TeamSlide. Launched in 2015, TeamSlide is a slide search solution for PowerPoint users in several fields including marketing, sales, and professional services. They enable customers to share knowledge, ensure consistent messaging, and drive productivity when building presentations. Kartik has a PhD in Bioengineering from Georgia Tech and later worked as a management consultant before launching TeamSlide. The Industry 4.0 Podcast with Grantek delivers a look into the world of manufacturing, with a focus on stories and trends that lead to better solutions. Our guests will share tips and outcomes that will help improve your productivity. You will hear from leading providers of Industrial Control System hardware and software, Grantek experts and leaders at best-in-class industry associations that serve Life Sciences and Food & Beverage manufactures.
Stryker, a global leader in medical technologies, has announced the launch of its Training Centre of Excellence, a new initiative that will help upskill employees, enhance leadership capabilities and foster manufacturing excellence at the company's facility in Tullagreen, Co. Cork. The three-year training initiative, developed with the support of IDA Ireland, will equip employees at Stryker's Tullagreen facility with the agility and skills for the future of work, promote innovative thinking, embed a culture of continuous improvement, and advance sustainability. This comes as the World Economic Forum estimates that six in 10 workers globally will require training before 2027 due to the changing nature of work and pace of technological change. Stryker's new Training Centre of Excellence in Tullagreen will feature a workforce transformation programme focused on upskilling and reskilling employees in every function of the business. This includes a focus on lean management and continuous improvement. Leaders at the facility will be provided with bespoke training to further enhance their agility and ability to develop high-performing teams. In addition, digital and automation engineers will train employees across the site on advanced technologies such as AI and how they can be harnessed to advance innovation and product development. The Training Centre of Excellence will also allow employees to pursue a range of courses and bespoke courses in Environmental Sustainability Awareness. The training programme will promote awareness and drive sustainability initiatives for Tullagreen. Speaking on the launch, Ian Corkey, Site Lead at Tullagreen Stryker in Ireland, said: "The launch of Stryker's Training Centre of Excellence in Tullagreen represents a significant step in our journey toward operational excellence and propelling innovation forward. By investing in our people and their skills, we can ensure that they thrive in a rapidly changing world and foster a culture of creativity and continuous improvement. "This new initiative will help future-proof our investment in our Tullagreen facility and strengthen our team's ability to develop cutting-edge products that help improve patient and healthcare outcomes long into the future. The Tullagreen Training Centre of Excellence will also serve as a lighthouse for other Stryker sites across Ireland. We are grateful to IDA Ireland for their invaluable support in bringing this initiative to life." Rachel Shelly, Global Head of Life Sciences at IDA Ireland added: "IDA Ireland welcomes the launch of Stryker's Training Centre of Excellence and is delighted to be partnering with Stryker on this important investment in its workforce. Stryker's mission is to make healthcare better. This is driven by the company's focus on innovation and performance, delivered through its world class team here in Ireland. The centre exemplifies the company's commitment to talent as an enabler for excellence in healthcare technology; and reinforces Ireland's role as a key partner for global MedTech companies. The launch of Stryker's Tullagreen Training Centre of Excellence builds on the company's annual apprenticeship programme as it reinforces its leadership in advanced manufacturing. Stryker first established a presence in Tullagreen in 1998 with an initial team of 20 employees. Over the past 26 years, the facility has expanded and evolved with employees now focused on manufacturing medical implants for joint replacement, spine and trauma and extremities which are positively impacting patients across the world.
Today's guest is Pranav Joshi. Pranav joins us on today's episode to explore the transformative intersection of technology, AI, and infrastructure in the life sciences industry. With insights drawn from years of experience, Pranav provides a unique perspective on how advancements in cloud technologies, endpoint storage, and AI are revolutionizing the pharmaceutical and healthcare sectors. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!
Lydia van der Meulen is hoofd van de Life Sciences & Healthcare Practice Group bij Pedersen & Partners Executive Search.***Volg Leaders in Life Sciences via de website.Volg Leaders in Life Sciences via LinkedIn.Bezoek www.henkjanout.nl voor meer informatie over de host.***Vragen, suggesties of feedback? Graag! Stuur een email naar: henkjan.out@me.com***Vind jij de Leaders in Life Sciences podcast leuk? Dan zouden we het enorm waarderen als je een recensie zou willen achterlaten op Apple Podcasts of een vijf sterren beoordeling zou willen geven op Spotify.Jouw steun betekent veel voor ons, omdat het anderen kan aanmoedigen om de podcast ook te gaan beluisteren. Heel erg bedankt!***Leaders in Life Sciences wordt mede mogelijk gemaakt door Pivot Park, Pedersen & Partners en Johnson & Johnson Innovative Medicine.
2024年的年終特輯又來啦！聽眾朋友們陪了我們那麼久，好奇三腳貓核心團隊的成員們各自是誰嗎？這集我們談談六隻三腳貓對彼此的第一印象，以及認識之後的反差，希望在歲末年終的時候能輕鬆地跟聽眾朋友們一起聊聊天！ 工作人員 內容製作：雯薇、若晴、Angel、天豪、浩文、Mike 後製：雯薇 文案：雯薇 音樂：雯薇 封面：雯薇 上架：雯薇 宣傳：Angel、雯薇 -- Hosting provided by SoundOn
Darshan's LinkedIn: https://www.linkedin.com/in/darshankulkarni/My PatientACE recruitment company: https://patientace.com/CRIO: http://www.clinicalresearch.ioInato: https://go.inato.com/3VnSro6Join me at my conference! http://www.saveoursites.comText Me: (949) 415-6256My podcast is Random Musings From The Clinical Trials GuruListen on Spotify: https://open.spotify.com/show/7JF6FNvoLnBpfIrLNCcg7aGET THE BOOK! https://www.amazon.com/Comprehensive-Guide-Clinical-Research-Practical/dp/1090349521/ref=sr_1_1?keywords=Dan+Sfera&qid=1691974540&s=audible&sr=1-1-catcorrText "guru" to 855-942-5288 to join VIP list!My blog: http://www.TheClinicalTrialsGuru.comMy CRO and Site Network: http://www.DSCScro.comMy CRA Academy: http://www.TheCRAacademy.comMy CRC Academy: http://www.TheCRCacademy.comLatinos In Clinical Research: http://www.LatinosinClinicalResearch.comThe University Of Clinical Research: https://www.theuniversityofclinicalresearch.com/My TikTok: DanSfera
Discover how this Nordic-US investment accelerator is transforming early-stage life sciences companies and creating unique opportunities in multibillion-dollar markets.In this exclusive interview, Henrik Rouf, CEO of Nordicus Partners (OTCQB: NORD), discusses the company's unique approach to accelerating Nordic life sciences companies into the US market. With decades of combined experience, their team identifies and develops promising biotech opportunities, focusing on treatments for diseases with significant unmet medical needs. Henrik shares insights on their current portfolio companies, Orocidin and Bio-Convert ApS, their strategic position bridging Nordic innovation with US market opportunities, and their debt-free growth strategy.Learn more about Nordicus Partners: https://nordicuspartners.com/Watch the full YouTube interview here: https://youtu.be/98BfFBNOgmoAnd follow us to stay updated: https://www.youtube.com/@GlobalOneMedia?sub_confirmation=1
Dec. 27, 2024 - State policy makers are betting big on the life sciences industry, investing millions in subsidies to promote and grow these businesses. We discuss a state report on the industry and its future with Winthrop Thurlow, executive director of the trade organization Life Sciences NY.
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm's Investigations + White Collar Defense Group, hosted the seventh episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector. In this episode, Kate and Nate spoke with Chen Zhu, a partner in Morrison Foerster's Investigations + White Collar Defense and FCPA + Global Anti-Corruption Groups, and James Koukios, co-head of Morrison Foerster's FCPA + Global Anti-Corruption Group and former senior deputy chief of the Fraud Section at the U.S. Department of Justice (DOJ). Together, they discussed anti-corruption and Foreign Corrupt Practices Act (FCPA) considerations and enforcement concerns for life sciences companies, especially those operating in both the U.S. and China.
In this episode of the MedTech podcast, Freshfields partner Vinita Kailasanath and Cimbal Capital Group principal Derek Underwood talk about his experience at the intersection of life sciences and tech, developing trends, and innovation in the space.
In the final episode of Moving Forward, Giving Back for 2024, Life Science Cares' (LSC) CEO Sarah MacDonald sits down with LSC founder and Chairman Rob Perez to reflect back on another exciting year and look forward to LSC's plans to scale both nationally and internationally to do what the organization does ‘better and bigger.' They examine how LSC's successful Project Onramp program continues to grow nationally as it expands into a number of new markets in 2025. Sarah and Rob also discuss the organization's ongoing effort to support and advocate for health equity nationally and how LSC plans to help the industry make a real impact around this very important concept in 2025. In conclusion, they detail how individuals and companies can get involved and help LSC to ‘care actively and make a difference for people' in the new year and beyond.
Subscribe, Rate, & Review on YouTube • Spotify • Apple PodcastsThis Week's GuestWhen, suddenly, the barrier between “imagination” and “reality” evaporates as our familiar notions of here/there, now/then, in/out, and other/self twist up into a ball of non-Euclidean spaghetti, whom better to help steer the course through these “turbulent philosophical waters” than Richard Doyle, aka “M0b1ius”, Edwin Erle Sparks Professor at Penn State Center for Humanities and Information in the College of Liberal Arts? After his postdoctoral research at MIT in History and Philosophy of the Life Sciences, Doyle wrote The Wetwares Trilogy, a sequence of books on the history of information biology that reached its climax with one of my favorite reads of all time, Darwin's Pharmacy: Sex, Plants, and The Evolution of the Noosphere. He is also the author of The Genesis of Now: Self Experiments with the Bible & the End of Religion and Into The Stillness: Dialogues on Awakening Beyond Thought (with Gary Weber), and has taught courses on “aliens, Philip K. Dick, nanotechnology, rebellion itself, ecstasy, Sanskrit rhetorical traditions, Burroughs, basic argumentation, The Non Dual Bible, and everything in between.” I discovered Doyle through his appearances on my first favorite podcast, Erik Davis' Expanding Mind, and in the thirteen years since he has shown up for me time and time again as mentor, friend, and inspiration. And since this project is, ostensibly, a way of training my own language model to reflect the wisdom of my friends and colleagues, I can think of no one else I'd rather prime the batch. It is my great privilege and honor to be able to have him as the first guest in this series, as a way of of helping set the tone for everything that is to come…LinksRichard Doyle's faculty web page and publicationsLearn more about this project and read the essays so far (1, 2, 3, 4).Make tax-deductible donations to Humans On The LoopBrowse my reading list and support local booksellersJoin the Holistic Technology & Wise Innovation Discord serverJoin the private Future Fossils Facebook groupHire me for consulting or advisory workChapters0:00:00 – Teaser0:03:36 – Episode Intro0:12:44 – Introducing Richard Doyle0:29:33 – The Ego as Inflammation0:33:58 – Practicing Care in The Planet-Wide Makerspace0:48:30 – Digital Connection vs. Embodied Connection0:55:46 – Psychedelics as Training Wheels for Transhumanism1:02:43 – “Storytelling” Isn't A Professional Service (??)1:05:25 – Techniques for Reclaiming Attention & Finding Peace1:15:22 – Meditation as “The Halting Problem”1:17:30 – Beyond The Limits of Science1:22:17 – AI-Enabled Extraction vs. AI-Enabled Abundance1:38:40 – Closing RemarksReflectionsMuch of tech ethics discourse concerns itself with whether humans are “in the loop” or “out of the loop” — whether people get to call the shots. But there is always more than one loop. Most of the things our fleshy bodies do are local decisions made before we ever become conscious of them, if we ever do…and yet evolution clearly found some value in reflection, self-awareness, reflex inhibition, and the will that quiets maladaptive impulse. Widening our frame to see the way that humans are always-already intertwingled with our ecosystems, we can see ourselves as made of interference patterns between nested feedback loops — as focal points of conscious agency dependent on and acting in a massive, endlessly surprising web of automatic processes. For as long as we've been people we have never really “called the shots” but rather cultivated our response-ability within a cosmos made of entities whose otherness and mystery remained persistently opaque…and ritualized ways to live amidst this mystery in full recognition of the unity from which we cannot isolate ourselves.And this is only one of indefinitely many valid ways to understand the human. Like the telescope and microscope before them, language models reveal fresh perspectives on familiar landscapes. We do not need to leave our solar system to find “strange new worlds” awaiting us in places as familiar as our own minds and bodies. While most of the conversation lately seems to be about the power these new maps confer and whether it can be distributed more evenly, AI provides a new set of affordances for mystics for the transformation of our consciousness that can dissolve our wicked problems in a higher logical order. “What can I do?” becomes “Who am I?” and yields endlessly evolving and kaleidoscopic answers that provoke ongoing inquiry. To see the ways in which we are, as individuals, not just “connected” but precipitate as aggregates, in fields of constellated data, prompts a figure-ground reversal in which selves no longer hold their primacy as ground truth of our being, but show up last as we make inferences and draw stories from unbroken and inseparable experience.Something fundamental changes when we shift to seeing “human” and “non-human” as two stable patterns of recursive self-perception emerging from a single fabric of unfolding possibility: we find the opportunity to question what we're trying to achieve, to notice the ungrounded and conditional reality of narrative, to operate on our own “source code” and adjust our goals accordingly.If we can find the curiosity to ask ourselves if our fears and inadequacies really help us live the lives we want, we can follow it upstream to where each moment offers fresh, distinctive landscapes in which to explore and play and learn. In doing so, we rediscover vast and potent creativity. Instead of asking whether we can do more, we can ask “What do we want to do, and why is that desire substantiated?”This kind of meaning-making isn't just a luxury but an essential aspect of all efforts to survive and to succeed. The best way to get unstuck is to orient ourselves and take a different tack. We all know something isn't working. It's time to ask if, maybe, this is due to “user error” and the answer doesn't lie in new technologies, but in the simplest and most ancient truths available. We cannot control the world because we are the world — and, this entails a sense of radical responsibility to play our way into more well-adapted stories, models of the world we hold with humor and humility as they carve channels in the space of shared attention that coordinate us into futures good and true and beautiful.In other words, the magical technologies inspiring so much religious fear and fervor are both Towers of Babel and fingers pointing to the Moon. They are weird, unprecedented, and sublime — and they are business as usual on Planet Earth, where we have always come awake in medias res amidst unfathomable changes and unknowable intelligence. Recognizing this, we gain access to deep continuity and the place from which we can, at last, engage the question of “What Now?” with discipline and limber rigor suitable to the profound complexity we face.Digital technologies are psychedelic. We've been on a bad trip. It's time for us wiggle out, dream better, and allow a more capacious, plural, and harmonious humanity to take the oars together in whatever novel wonders may arise — to neither “give way to astonishment” nor let our fears steer us into the rocks. Humans On The Loop is an investigation of how awesome it could be, right now, to fully give in to the paradox, and notice how its knots untie in hyperspace, and revisit all our looming crises with more presence, grace, and understanding — and more lucid (dare I say, productive?) questions.One of those questions is how to apply the lessons of the living generations of psychonauts and psychedelic therapists to the vertiginous information and attention vortices in which we now found ourselves swirling. Maps of the World Wide Web look very much like brain scans of the amped-up functional connectivity between ordinarily inhibited brain regions in a psilocybin tripper. When the walls come down — when every node has edges with each other node, and average path length drops to one — how do we prioritize? What paths do we decide to cut through the emergent “intertwingularity”? Which apparitions do we honor, and which do we ignore? (And how?) Some familiar tropes that we might use to guide us: “test your drugs”, “get grounded”, “set and setting”, “integration counseling”…MentionsGenerated by NotebookLM. Please let me know if you notice any errors or omissions!* Richard Doyle* Michael Garfield * Gary Weber* Shankara* Trey Conner* Nora Pandoro* Erik Davis* Joshua DiCaglio* John Perry Barlow* Naomi Most* Nate Hagens* Daniel Schmachtenberger* Tyson Yunkaporta* Martin Luther King Jr.* Mahatma Gandhi* John Von Neumann* Subhash Kak* Iain McGilchrist* Timothy Morton* Stuart Kauffman* Dean Radin* Brian Josephson* Monica Gagliano* Christoph Koch* Gregory Bateson* Elon Musk* Robert Rosen* H.P. Lovecraft* Philip K. Dick* Herbert Simon* Douglas Rushkoff* Sri Aurobindo This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe
Join us for a short series examining the DOJ's recent Notice of Proposed Rulemaking (NPRM) on cross-border data transfers and its potential to reshape global data flows from the US to China and other “countries of concern.” We'll explore the NPRM's implications for national security, compliance programs, data governance and the unique impact it will have on the health and life sciences sectors. The impact on the health and life sciences industry Finally, in Episode 3, Scott continues the discussion with partner Mike Druckman to explore the unique impact of the proposed rule on the health and life sciences sector, including new standards for sensitive data such as genomic information and biospecimens.
This episode features a conversation with Shweta Maniar, who leads the Healthcare and Life Science effort at Google cloud. In just a few short years, artificial intelligence has gone from the stuff of hype and fairy tale to powerful and ubiquitous tools for all aspects of R&D and healthcare delivery. Google has been central to this sea change. I discuss with Shweta how her organization helps make these advanced capabilities available to the masses, and so much more. Join us! Episode 41 links: TPM E41 for highlights and links from this episode > Genialis™ Supermodel Happy Holidays Genialis' Upcoming Events Genialis on LinkedIn
On this episode of the Crazy Wisdom Podcast, host Stewart Alsop welcomes Swati Chaturvedi, CEO of Propel X, to explore the world of deep tech, frontier technology, and the forces shaping the future of human progress. Swati shares her decade-long journey in deep tech, reflecting on how the term evolved as a response to the "tech startup" boom, and discusses her focus on companies leveraging breakthroughs in science and engineering for humanity's advancement. The conversation touches on the role of government support, the power of hypothesis-free experimentation, and the critical importance of partnerships between startups and large corporations. They also discuss transformative technologies like AI, autonomous drones, bioinformatics, robotics, and the possibilities and perils of human augmentation. For more insights from Swati, visit Propel X at www.propelx.com or connect with her on LinkedIn, where she shares her thoughts on innovation, R&D, and the future of technology.Check out this GPT we trained on the conversation!Timestamps00:00 Introduction to the Crazy Wisdom Podcast00:16 Defining Deep Tech and Its Evolution03:06 Challenges and Philosophical Insights in Deep Tech07:07 AI's Role in Engineering and Bioinformatics14:22 Future Shock and Human Augmentation14:35 The Evolution of Science and Technology22:58 The Future of Work and Social Dynamics24:06 Exploring Sci-Fi Genres: Cyberpunk vs. Solarpunk25:25 Exploring Solar Punk and Human Problems26:01 The Promise and Limitations of Deep Tech26:39 Economic Realities of Technological Advancements27:16 Future Impact of Emerging Technologies28:58 Challenges in Ag Tech and Environmental Concerns29:30 Global Environmental Change and Human Activity33:53 The Role of Modeling in Predicting Climate Impacts36:22 Scientific Method and Industry Collaboration39:23 Government's Role in Early Stage Research42:34 Investment Strategies in Deep Tech46:27 Consumer and Corporate Markets for New Technologies49:12 Conclusion and Future DiscussionsKey InsightsThe Rise of Deep Tech as a Distinct Category: Swati Chaturvedi explains how the concept of "deep tech" emerged as a response to the overuse of the term "tech startup" during the heyday of consumer technology. Unlike simple software apps like photo-sharing or delivery platforms, deep tech focuses on companies leveraging scientific and engineering breakthroughs to solve fundamental human challenges. This includes innovations in fields like AI, robotics, life sciences, space technology, and advanced materials. Her 2014 blog post defining deep tech has since become a widely referenced resource in the field, signaling a shift in focus from digital consumer solutions to tangible, science-based advancements.The Role of Hypothesis-Free Experimentation: Traditional scientific research follows a hypothesis-driven approach, where scientists predict outcomes before testing. Swati highlights the transformative potential of "hypothesis-free" experimentation, where AI and machine learning allow for large-scale experimentation without predefined assumptions. This approach mirrors the randomness of evolution, enabling faster discovery of unexpected results. Companies like Helix are applying this method in drug discovery, where AI-driven processes identify new therapeutic compounds. This shift could significantly accelerate R&D timelines and reduce costs in fields like pharmaceuticals and materials science.The Power of Government Support in Early-Stage R&D: Swati emphasizes the essential role of government funding in de-risking early-stage research. Through programs like SBIR (Small Business Innovation Research) grants, government agencies like the NSF (National Science Foundation) and the Department of Defense (DoD) fund exploratory research at universities and small businesses. These grants act as the "seed fund of America," investing billions annually into high-risk, high-reward projects. Companies that receive these grants often have their private sector investments matched by government dollars, providing significant leverage for investors and entrepreneurs. This public-private funding model enables startups to bridge the "valley of death" between research and commercialization.The Critical Role of Corporate-Startup Partnerships: Swati highlights the importance of partnerships between startups and established corporations, especially in deep tech. These joint development projects allow startups to access resources, validate their markets, and co-develop products with corporate customers. While some founders worry about protecting their intellectual property (IP), Swati believes that the benefits of corporate partnerships outweigh the risks. Corporate collaborations offer crucial early traction and revenue, helping startups de-risk their path to market. This is especially vital in sectors like healthcare, robotics, and clean energy, where the cost of developing and commercializing products is exceptionally high.AI as a Force for Human Augmentation: The episode explores AI's role as an augmentative force rather than a replacement for human intelligence. Swati notes that AI is best understood as a tool that allows humans to multiply their cognitive abilities—processing vast amounts of information, identifying patterns, and making faster connections. This augmentation goes beyond software, extending into physical augmentation with devices like robots and smart tools that help humans accomplish physical tasks. While AI-driven tools like ChatGPT may lead to job displacement, Swati sees it as a natural progression, requiring humans to upskill and shift to higher-value tasks.The Promise and Risks of Climate and Environmental Technologies: Swati identifies climate change and global environmental degradation as existential challenges that even the most advanced deep tech may struggle to address. Technologies like atmospheric water generation, carbon capture, and agtech are making strides, but she notes that they are not yet sufficient to solve global challenges like water scarcity, food security, and air pollution. Drawing from her personal experience with air pollution in India, Swati argues that we need to better price and internalize the "cost of the commons"—the shared environmental resources that are often depleted for private gain. Without a clear economic incentive to prevent environmental harm, she warns that climate issues will continue to escalate.The Future of Space Tech and Human Exploration: Swati expresses optimism about the commercialization of space technology, noting its growing impact on daily life. Technologies like satellite internet (e.g., Starlink) are already improving connectivity in remote areas worldwide. The use of satellites for earth observation, weather tracking, and resource management is also becoming essential for sectors like agriculture and disaster response. Looking ahead, Swati is bullish on the potential for space colonization on the moon and Mars, although she acknowledges the immense technical and ethical challenges involved. While space tech once felt like science fiction, companies like SpaceX have made it tangible and real.
In this episode of Life Science Success, my guest is John McDonough, the Executive Chairman and CEO of Sunbird Bio. John is a seasoned life sciences executive with over 30 years of experience, known for his impressive track record of raising capital and creating substantial market value. He currently leads Sunbird Bio, a company at the forefront of developing innovative blood-based diagnostic tests for neurological disorders, particularly Alzheimer's disease. John's expertise extends beyond Sunbird Bio, as he also serves as chairman at Cytrellis Biosystems and BioPorto Diagnostics, and is the founder and president of the Crush Colon Cancer Foundation. With a history of successful IPOs, acquisitions, and mergers, John brings a wealth of knowledge and experience to our conversation about the future of neurological diagnostics and the life sciences industry. 00:00 Introduction to Life Science Success Podcast 01:20 Interview with John McDonough Begins 01:44 John McDonough's Career Journey 03:33 Challenges and Opportunities in Diagnostics 05:24 Significant Changes in Life Sciences 08:10 Sunbird Bio's Vision and Innovations 10:27 Development and Impact of Blood-Based Diagnostics 12:23 Future of Diagnostics and Neurological Disease 27:01 Philanthropy and Leadership Insights 28:36 Securing Funding and Company Growth 35:40 Leadership Advice and Personal Inspirations 42:31 Conclusion and Final Thoughts
Today's guest is Chloë Domergue, Principal in the Human Capital Practice at Deloitte. Chloë joins us on today's program to explore the evolving impact of AI and agentic systems within the life sciences sector. She shares her unique perspective on how technological advancements, particularly generative and agentic AI, are reshaping not just operations but the fundamental nature of the workforce. Together with Emerj Senior Editor Matthew DeMello, Chloë dives into the pressing challenges life sciences organizations face, such as hiring and upskilling talent for a future where AI-driven agents work alongside humans. This episode is sponsored by Deloitte. Find out more about sponsored content and how to engage with the Emerj audience at emerj.com/ad1.
Veckans podd gästas av Life Science investmentbolaget Flerie. Ett nytt investmentbolag på stockholmsbörsen sen i somras. Vi gästas av vd Ted Fjällman för att höra mer om resan till börsen, vilka typer av bolag de investerar i, exit-planer, framtida portföljförändringar och mycket mer. Inte minst vad de planerar att investera sina 900 miljoner kronor som finns i kassan framöver. Lyssna in.
Unlocking the Power of AI Analytics for Small and Medium BusinessesIn a recent episode of "The Thoughtful Entrepreneur," host Josh Elledge engaged in a compelling conversation with Krunal Patel, the co-founder and Chief Product Officer of Bordo AI. The discussion centered around the transformative potential of AI analytics in helping small and medium businesses (SMBs) and financial institutions better understand their customers and make data-driven decisions. This blog post delves into the key themes and insights from the episode, offering actionable advice and expert recommendations for leveraging AI in business.Krunal Patel introduces Bordo AI, an AI analytics platform designed to assist SMBs and financial institutions in gaining deeper insights into their customers. The platform leverages transaction and sales data to help businesses understand their customer base better, convert one-time customers into loyal ones, and identify opportunities for cross-selling and upselling. Krunal explains the necessity of AI analytics in today's business landscape, noting that while the need for advanced analytics has existed for some time, the underlying technology was not available until recently. With the rise of generative AI, the maturation of machine learning models, and the decreasing cost of computing power, now is the ideal time to build solutions that promote financial equity.The conversation shifts to the topic of critical thinking and decision-making. Josh highlights the tendency for individuals to make decisions based on emotions, which can sometimes lead to flawed judgments. Krunal agrees, stating that the goal of Bordo AI is to augment human decision-making, not replace it. AI can enhance decision-making by providing additional data points and insights. The episode concludes with Josh thanking Krunal for the insightful conversation and encouraging listeners to explore the potential of AI in their own businesses. By combining human intuition with advanced AI analytics, businesses can achieve optimal outcomes and stay competitive in today's dynamic market.About Krunal Patel:Krunal Patel is a seasoned product and engineering leader with over 20 years of experience across multiple industries, including Finance, Life Sciences, Healthcare, and Public Safety. He specializes in driving innovation through SaaS and AI products, with a proven track record in developing cutting-edge solutions. As a two-time founder, Krunal successfully raised $10M in seed funding for an AI enterprise platform and scaled a SaaS analytics platform from 5 to 1,800+ trials, achieving a 50% YoY revenue growth. He has led global product and engineering teams of up to 75 people across four countries and holds a patent for "Abstractly Implemented Data Analysis Systems and Methods."Krunal's expertise spans the full product lifecycle, from ideation to market launch, and he is skilled at leveraging AI, ML, and cloud computing to create data-driven solutions. He is passionate about building and mentoring high-performance, diverse teams and aligning product development with strategic business objectives. With a user-centric, agile approach, Krunal is committed to delivering genuine customer value and fostering continuous innovation to drive long-term success.About Bordo:Bordo is an AI software-as-a-service (SaaS) that helps organizations connect, contextualize, and derive deep-rooted insights from their high-dimensional data.Equip your teams with our Explainable & Context-Aware Recognition AI, experienced through an intuitive, conversational interface.Apply to be a Guest on The Thoughtful Entrepreneur: https://go.upmyinfluence.com/podcast-guestLinks Mentioned in this...
In this episode, Dr. Alexandria Wise celebrates 15 years of innovation at CNS Summit 2024 by sitting down with Kevin Craig, Senior Vice President of Clinical Development at atai Life Sciences. Recorded from the floor of the conference, Kevin shares his journey from research and medicine to leading drug development in mental health, with a focus on the company's pioneering work in psychedelics.This episode delves into the complexities of drug development in the psychedelic space, the importance of global accessibility, and the profound impact of patient involvement in clinical trial design. Kevin also shares his perspective on the future of the life sciences industry, emphasizing the role of big data, biomarkers, and efficient trial models in advancing mental health care.The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.
In this Vital Health Podcast, John Stanford, Executive Director of Incubate, discusses the impact of the Inflation Reduction Act (IRA) on venture capital investments in life sciences. Stanford emphasizes that the IRA's price control mechanisms have led to significant shifts in funding, particularly away from small-molecule drug development, creating what is described as the "small molecule penalty." Key points include: Venture Capital's Role and Challenges: Venture capital is critical in translating basic research into medicines. The Inflation Reduction Act has disrupted this ecosystem, discouraging investment in certain drugs due to anticipated lower returns under price control regimes. Data from the Life Science Tracker: Stanford highlights the Life Science Tracker findings, showing 36 research programs and 21 specific drug developments discontinued since the IRA's passage. Notably, investments are markedly shifted from small molecules to biologics. Economic and Patient Impact: The IRA has led to reduced innovation in critical areas like oncology and rare diseases. Treatments for diseases like ovarian cancer and blindness have been deprioritized. Stanford argues that the act inadvertently penalizes older patients, the demographic it was designed to benefit, by disincentivizing drugs for age-related diseases. Proposed Solutions: The EPIC Act, a bipartisan effort supported by Incubate, aims to address the disparities by giving small molecules the same 13-year exclusivity period as biologics. Fixing the incentives for drug development, including addressing multiple indication penalties, is crucial to fostering innovation. Critique of Government Assessments: Stanford critiques the Congressional Budget Office (CBO) for its reliance on limited data sources and narrow time horizons, which fail to capture the long-term impacts of the IRA. In conclusion, Stanford stresses the need for legislative adjustments to mitigate the IRA's unintended consequences on drug innovation and patient care. For more insights, listeners are directed to the Life Science Tracker at lifesciencetracker.com.See omnystudio.com/listener for privacy information.
Recorded at NC Life Sciences Organization's Annual Meeting, Heather and Lauren welcome David Robinson, an attorney at Maynard Nexsen, who also serves as the Honorary Consul for Japan in North Carolina and Chairman of the NC Consular Corps. David joins us to share his unique insights on Japanese companies doing business in North Carolina and trends in international investment in the state's life sciences industry. Tune in now!
Many VCs, particularly newer firms, readily admit that 2024 has been a challenging year for raising fresh capital. Dimension Capital, a two-year-old venture outfit, had a different experience when raising its second fund. “Every investor from fund one came back very quickly." Learn more about your ad choices. Visit podcastchoices.com/adchoices
Mike Switzer interviews John Warner, a serial entrepreneur and founder of Innoventure in Greenville, S.C., to discuss Charleston being named the fastest-growing life sciences hub in the country.
What if you could get more done in less time? That would sure come in handy around the holidays – or any time. This episode begins with a simple strategy that works great even though only one in five people do it. http://www.balancetime.com/ Every culture on the planet has some sort of religion. Why? What is it that religion does for people that makes it so popular? For one thing, people who practice a religion – any religion – report some real benefits to their life, health and longevity according to David DeSteno author of the book How God Works: The Science Behind the Benefits of Religion (https://amzn.to/3AWs2Vx) and host of the podcast How God Works (https://www.howgodworks.org). Listen as David reveals the scientific findings that explain why religion is so important to people, what the benefits are and how anyone can reap those benefits regardless of what religion you believe in. Would you want to live in outer space? What would happen to your body and mind living miles above the earth? When you think about it, we humans aren't built to live without gravity. We've always had it. So, what happens if you go for long periods of time without it? Here to address all of this is someone who has actually lived in space for a long time – TWICE! Dave Williams is an astronaut, pilot, ER physician, former Director of Space & Life Sciences at NASA's Johnson Space Center and author of the book, Why Am I Taller?: What Happens to an Astronaut's Body in Space (https://amzn.to/3FoI5xK). Listen as he reveals the challenges of living, sleeping, eating, and everything else in zero gravity. I'm sure you have heard the phrase, “That's a whole nother story…” But wait a second! Is nother really a word? Listen as I discuss what the “nother” in “a whole nother story” is all about. PLEASE SUPPORT OUR SPONSORS!!! INDEED: Get a $75 SPONSORED JOB CREDIT to get your jobs more visibility at https://Indeed.com/SOMETHING Support our show by saying you heard about Indeed on this podcast. Terms & conditions apply. AURA: Save on the perfect gift by visiting https://AuraFrames.com to get $35-off Aura's best-selling Carver Mat frames by using promo code SOMETHING at checkout! SHOPIFY: Sign up for a $1 per-month trial period at https://Shopify.com/sysk . Go to SHOPIFY.com/sysk to grow your business – no matter what stage you're in! MINT MOBILE: Cut your wireless bill to $15 a month at https://MintMobile.com/something! $45 upfront payment required (equivalent to $15/mo.). New customers on first 3 month plan only. Additional taxes, fees, & restrictions apply. HERS: Hers is changing women's healthcare by providing access to GLP-1 weekly injections with the same active ingredient as Ozempic and Wegovy, as well as oral medication kits. Start your free online visit today at https://forhers.com/sysk DELL: Dell Technologies' Cyber Monday event is live and if you've been waiting for an AI-ready PC, this is their biggest sale of the year! Shop now at https://Dell.com/deals Learn more about your ad choices. Visit megaphone.fm/adchoices
On this Astonishing Healthcare podcast episode, Tom Evegan, Principal, National Consulting Leader, Life Sciences at RSM, a leading provider of tax, assurance, and consulting services in the US, joins Justin Venneri for a discussion about topics ranging from health policy to drug pricing and how to provide equitable drug access. Tom shares his background and path to RSM, explaining how his experiences at a major pharmaceutical manufacturer, pharmacy benefit manager (PBM), and a biotech launching a new therapy shaped his experience and aided him in becoming a "gross-to-net expert."Tom has helped hundreds of drug manufacturers launch, acquire, or divest assets and bring products from the regulatory phase to commercialization, so he's seen a lot and pays close attention to issues impacting drug prices and market access. Given his broad experience across the pharmaceutical supply chain, almost no topic is off the table. The conversation dives into the Inflation Reduction Act (IRA), the Chevron Ruling and 340B program, AI, why rebates likely aren't going anywhere soon, and the most astounding thing Tom's seen (hint: it relates to GLP-1s)!Related ContentHow to Manage Pharmacy Benefit Spend in a GLP-1 WorldAH021 - Managing Pharmacy Costs in a GLP-1 World, with Bridget MulvennaWhat is NADAC & How Does It Differ From AWP?AH022 - Pharmacy Benefits 101: Pharmaceutical Rebates, with Ben SchusterTo connect with Tom or for more information about RSM's Life Sciences Group/Management Consulting Services, please visit:Connect with Tom Evegan (LinkedIn)Life Sciences | Industries | RSM USScaling at the Speed of Change: BiopharmaFor more information about Capital Rx and this episode, please visit Capital Rx Insights.
This year, we commemorated National Disabilities Employment Awareness Month by exploring how employers can work toward providing access to good jobs for persons with disabilities in the legal profession; the tangible benefits of employing persons with disabilities; the feasibility of providing accommodations; and the use of assistive technology. Our speakers provided their thoughts on best practices, shared personal journeys and insights, and reflected on how far employers have come and where we need to focus to increase future employment opportunities for persons with disabilities in the legal profession and beyond. Our guests included Kevin Hara: Counsel, Reed Smith; Ronza Othman: President, National Association of Blind Government Employees – a division of the National Federation of the Blind; Nicholas Carden: Associate General Counsel, Coinbase, and former Board Member of Disability:IN; and Laurie Allen: Microsoft, Senior Accessibility Technology Evangelist. ----more---- Transcript: Intro: Welcome to the Reed Smith Podcast, Inclusivity Included, Powerful Personal Stories. In each episode of this podcast, our guests will share their personal stories, passions, and challenges, past and present, all with a goal of bringing people together and learning more about others. You might be surprised by what we all have in common, Inclusivity Included. Kevin: Hello, everybody. Welcome back to an episode of Inclusivity Included. Thank you, everyone, for joining. My name is Kevin Hara. I'm counsel at Reed Smith in the Life Sciences and Health Industries Group, and I'm proud to commemorate National Disabilities Employment Awareness Month, which is in October of every year. And this year's theme is access to good jobs for all. We have a number of distinguished panelists today joining us, including Ronza Othman, who is president of the National Association of Blind Government Employees, a division of the National Federation of the Blind. Nick Carden, associate general counsel from Coinbase, a former board member of Disability:IN. And Laurie Allen from Microsoft, a senior accessibility technology evangelist. So thank you, Ronza, Nick, and Laurie for joining us. We're thrilled to have you here as part of our podcast. And without further ado, I would like to ask Ronza to talk a little bit about your journey, how you have arrived where you are, and some of the important steps you took that led you to where you are today. Ronza: Great. Thank you so much. I'm really delighted to be here. I am a blind attorney and my training was initially as a high school STEM teacher. And that's what I did to get myself through law school. And ultimately I've had a number of different legal jobs, but in state and local government and private sector, ultimately ended up in the federal government where now I manage civil rights programs for a large federal agency. And so my journey has been one of exploration and learning, not only because, you know, being a lawyer, an attorney is always difficult for any person, but also when you add the complications of inaccessible technology and perceptions about people with disabilities and what they can and cannot do, and the obstacles that those negative attitudes create, there's definitely been some really interesting experiences along the way, but I think that I'm optimistic in terms of where we are now. So my paid job, of course, is with the government. And as a volunteer, I serve as the president of the National Association of Blind Government Employees, where we have a number of blind and low vision employees of state, local, federal, and pseudo-government agencies that are members that are experiencing life as public servants, supporting this country at the local and state and national level. It is an honor to represent them and us in a variety of different circumstances, and I've gotten to do a lot of really cool things as a result. Kevin: That's great. Thank you so much, Ronza. And Nick, if you'd like to share a little bit about your path that led you to where you are today. Nicholas: Thanks, Kevin. And thanks to Reed Smith for having us. This is a great opportunity to speak about an important issue that impacts all of us on this call. I, like Ronza, I am a lawyer with a disability. I started my career right out of law school in-house, which is somewhat unusual, but it sort of led me to where I am today in the sense that early in my career, I was a true corporate generalist, and through various personnel changes and responsibility changes, I was at a consumer products manufacturing company and had the opportunity to pick up some, advertising and marketing and entertainment legal work. And I really enjoyed that type of work. It's a lot of fun. It's fast paced and it's highly creative and interesting work. So I've stayed in that sort of practice area as an in-house lawyer through my career to today where at Coinbase, I lead a global marketing legal team. Kevin: Great. Thank you, Nick. And Laurie, we'd love to hear a little bit about the path you took to where you are today. Laurie: Thanks, Kevin. And thank you again for inviting us to join you to talk about this great topic. So I am not an attorney. I work at Microsoft, as you mentioned. And I've been in tech for about 30 years. I've only been at Microsoft for a little over two. But my journey actually into accessibility started about nine and a half years ago when I had a spinal cord injury. and became quadriplegic. The only thing that didn't dramatically change about my life in that moment was my ability to do my job. And that's because of accessible technology that was available to me. And frankly, my job was quite literally a lifeline for me. So I'm so grateful that people came before me to create this technology. And about three years ago, I had this epiphany. How did this technology get created? And who built it? And why am I not part of the solution. So that's when I started pivoting my career into accessibility. So I feel quite fortunate to be in a role where I can combine my background in technology with my lived experience as a person with disability to help empower others like me, find meaningful employment, and succeed and thrive. Kevin: Thank you so much. All of you have had such unique experiences and out to the successful careers that you are now engaged in today, but it hasn't always been easy for persons with disabilities in the legal profession and other professions to succeed. So I'd like to stay with you, Laurie, and to ask you, what do you believe are some of the barriers or challenges for persons with disabilities to find access to good jobs? Laurie: And I think Ronza had mentioned it earlier, it's access to technology. It's discoverability, I find, that can be a barrier. People just don't know what technologies are available to support them in their work environments. And beyond that, it's finding companies who've built inclusive work environments for employees with disabilities, so that when they go through the interview process, they feel included, they feel supported, and as they're onboarded and as they can continue through their career. And then understanding that there are platforms that are available, like Mentra, for example, is a Microsoft partner. It's an amazing neurodiversity hiring platform. But I think just knowing what's available is sometimes quite difficult. And, you know, when people incur a disability like I did, they're starting from scratch, and they don't know what to ask for because it's a new environment for them. Kevin: Thank you. That's a really good point. Having the access to the proper tools is key for anybody with a disability to succeed in any career path. Ronza, how about your perspective? How would you characterize some of the challenges people are facing and ways to overcome them? Ronza: I think that the biggest challenge that the people with disabilities are really facing in terms of employment and just moving about society and contributing meaningfully in employment settings, but also in every setting, is the negative attitudes that people at large have about disability. Negative stereotypes. The unemployment rate for people with disabilities in the United States is over 50%. The unemployment rate for people who are blind and low vision in the United States is half again that almost at 75%. It's currently at 73%. That's mind boggling. These are people who want to work for the most part, but can't because nobody will hire them or because they don't have the proper training to be able to perform the jobs where there is a need. But all that really comes down to society's low expectations for people with disabilities and the barriers, artificial, usually, that society creates and puts in our way. One of the things that I really like to do as a hiring manager is I love meeting with and interviewing people with disabilities because they're so creative in their problem-solving. Their solutioning is out of the box thinking. And just to get to work in the morning, to get to the job, they have to have solved a whole bunch of problems in an environment, in a situation, in a society, not necessarily built for them. Whether it's the broken elevator, or whether it's the bus that didn't roll up to the bus stop where it was supposed to, or whether it's the technology that didn't work because somebody pushed a security update, so it broke its ability to communicate with assistive technology, or whether it's somebody, a well-meaning, you know, abled person who decided that they know where this person is trying to go and they're going to force them to go there as opposed to where the person is actually trying to go. All of those things, people with disabilities problem solve before they, you know, really start their day or as they're starting their day. And so I think we don't give enough credit to the workforce of folks with disabilities in terms of what they can do, what they have done, frankly, and then society just has negative expectations. The biggest aspect of disability isn't the disability itself. It's people without disabilities or people who don't understand disabilities who get in our way. Nicholas: I'd love to add to that because I agree with a lot of that. And I think thinking about access to jobs, the question that comes to mind to me is, do employers want to hire persons with disabilities. And I think there's no clear answer to that. And obviously, companies themselves are just made up of other human beings. And so there's, to Ronza's point, the stigma attached to hiring persons with disabilities is ever present. But I'll share specifically in the legal industry, I think this industry does a particularly poor job of being intentional about hiring a truly diverse workforce. And this is, I'm calling out the legal industry as somebody who's in it, but I don't think it's unique to the legal industry in the sense that I still don't think when law firms are hiring for diverse candidates that they make a particular effort to recruit persons with disabilities. I think it can be as simple as asking for a voluntary disclosure on an application. And I still don't think as an industry we're doing those types of things. So there seem to be opportunities if the answer to the question of do you want to hire persons with disabilities is yes. Ronza: I'll just add to that, if I may. When you look at the United States census data on people with disabilities, somewhere between 20% and 25% of the population of this country has a disability. When you look at the census in the legal profession, when you look at the numbers in the legal profession, and the American Bar Association has done extensive research trying to sort this out, figure it out, as some other entities, it's less than 1%. Less than 1% of attorneys in the United States are willing to disclose that they have a disability. And those who are, it's usually an obvious or very visible disability, as opposed to some of these hidden disabilities that there's still so much stigma in the legal profession around. In the regular generic work industry generally, not specifically the legal profession, but everywhere, there's this misconception that it's going to be really expensive to hire somebody with a disability because you have to accommodate them or you have to adjust schedules or policies and so forth and so on. The Job Accommodation Network, which is a free resource to employers and employees about what's available in terms of reasonable accommodations for those with disabilities, did a study and they determined that the average cost of a reasonable accommodation is less than $100. So talking about negative attitudes and negative perceptions, one of them for employers, It's that it's going to cost me a lot of money or somehow the work I'm going to receive from this person is going to be less in terms of quality or quantity than other non-disabled employees and so forth and so on. And all of that is just not accurate. It's not supported by research and it's certainly not supported by those of us in the community with lived experience in the workforce. Kevin: That's an excellent point, Ronza, and Nick as well. You both have captured the problem that we're facing in providing good jobs to persons with disabilities. I think dispelling the myths and misconceptions is one of the important steps. And I also think technology can play an important role. We alluded to this a little bit more, but Laurie, if you would like to speak a little bit more about how technology can really help people with disabilities succeed. Laurie: Thanks, Kevin. So the way we approach it at Microsoft is we build with the community, not for the community. We mentioned it in the last question. We bring people with lived experience into our company. We want that diverse lived experience in our product making. I have a spinal cord injury. I know what it's like to have a mobility disability. I don't know what it's like to be blind and rely on a screen reader. And I can't assume what someone who uses a screen reader needs. So we take an approach of building in early. We build in accessibility into the design phase of our product development life cycle. We bring testers in who have different types of disabilities to test our products before we release them. And what we find, and Ron's mentioned it earlier, is that we get really creative solutions because, as she mentioned, we have to be creative to get out the door every morning. And when we do this, we find that everyone benefits. When we call it Built for One, Extend to Many. When we build with the disability community, everyone benefits. And I'll give you an example. For example, live captions were built for people who are deaf or hard of hearing, but 50% of Americans watch videos with live captions on, and if you narrow that down to Gen Z, it goes up to about 80%. So when we build for people with disabilities, everyone benefits. Kevin: I think that's a really astute observation. It's not just about helping one particular segment, but including people with disabilities when you're building the technology is really important. And, you know, I couldn't thank you more for that approach, Laurie, because, you know, I also have a mobility disability, a spinal cord injury. So I understand from my perspective. But as you said, I wouldn't be able to talk about or understand what the needs of a person with a visual or other disability might be. So that's really good. And Ronza or Nick, would you like to weigh in on technology, how it has helped you, or how do you think it can help others? Ronza: So technology really is, it leveled the playing field for many populations within the disability community. And so, for example, for the blind community, so much of the information that we receive is visual. So much as paper had historically been paper-based but you know street signs billboards all of the things that happen visually and on the computer though now we can have access to that same information or I can go to an ATM machine and I can plug in my headphones and I can pull out my money I can go to a voting booth in most states and I can privately and independently but vote my ballot. You know there's still places where of course there's work to do but in general the proliferation of technology solutions over the last 20 or 30 years has really made a huge impact on our ability to access information engage in the world and especially with our jobs, so whether it's a screen reader or whether it's a software that's used that is speech to text for those with manual dexterity challenges or whether it's a foot pedal instead of a mouse or whatever the case may be. There's just been such advances in technology that have made it more possible for an individual with a disability to work in so many different fields. Think about all the technology that exists now. Surgeons are doing surgery with robots some of the time. Technology is super cool. It's super advanced and it's only going to get more and more advanced. And so hopefully that means that participation of the disability community at work and in other places is also going to increase. Now, the drawback is, the more innovated the technology, the more risk of potential opportunities to make it inaccessible. And so we have to be really careful when we embrace technology because that's really important, but that it also is accessible. It is compatible with that assistive technology that I mentioned, but also that we're not so focused on creativity and innovation that we're cutting people out that we've recently gave access to these platforms and applications. And we're seeing that. We are seeing technology become less inclusive in lots of different spaces. And then, you know, so build it accessibly, you know, talking to our friends at Microsoft and everywhere else who are thinking about this every day. But also, whether we're building technology or whether we're building buildings or physical spaces or virtual spaces, you know, thinking about what does it mean for us to be inclusive? Who are we building for? And not related to technology, but when we started putting in curb cuts when the ADA was passed, that was primarily done for people who were using wheelchairs and other kinds of mobility devices. And now the population that is the most vocal, the biggest fans, are parents and caregivers of small children that are pushing strollers. And so, you know, again, that sort of universal effort, the Ray-Ban Metaglasses is another example. It wasn't built for people with disabilities, but people with disabilities are using it because it had inclusive universal design built into it. We're using it to read menus and help with navigation indoor and outdoor and wayfinding and all sorts of amazing things happening with technology and beyond. So the key is it's fabulous, but we also have to make sure that it stays fabulous by being inclusive and accessible. Laurie: You make such a good point there, Ronza, and I think with this wave of generative AI and everyone racing to get products to market, it's more important than ever to be rigorous and disciplined in continuing to build accessibility in from the beginning and test it thoroughly all the way through before it's released. Ronza: 100%. Kevin: Ronza and Laurie, those are excellent points that you made. And I really think technology will go a long way to helping people with disabilities of all types become part of the workforce, become part of the legal profession. And I think we have all lived through recently the pandemic that, you know, was affected everyone, not just persons with disabilities. But I think one of the things that came out of that was the importance of remote work and how that can really change the landscape. And Nick, I believe Coinbase is, you said, almost all remote. So can you comment on how that has impacted you and how you think that affects people with disabilities in terms of having access to jobs? Nicholas: Yeah, Coinbase is a remote first company. So everyone in the company has the option to be remote first. We do have some office locations in some major cities if some people feel like they want to go into an office, but there's no requirement to do that. And in my view, I don't know that remote work benefits just persons with disabilities. I think we can all agree that it benefits a lot more groups than just persons with disabilities. To me, the bottom line of the benefit of remote work is it levels the playing field for everyone. So if we're all remote, we don't. There's no small group or other group or specific individual or groups of individuals that have to worry about what's happening in an office. Are some people getting ahead by having lunches or just getting that face time that they otherwise aren't able to do to be into the office? Whether that's because they live somewhere else where the office isn't, or they're a person with a disability and it's not easy to get into the office, or for any other reason of why it doesn't make sense. I think specifically for parents with children who are working. Remote work is a great benefit. So I love what remote work does for everyone. And it's been a real benefit. I think Coinbase deserves a lot of credit. For being one of the first companies in I think it was may of 2020 to decide that is how we're going to operate our company we think we can do it effectively and so far now you know four plus years later they're doing really well and um i don't have any knowledge that that Coinbase is changing their practices but it works very well for Coinbase and I'm sort of discouraged to see some of these companies deciding to go to a hybrid or fully return to office status. But obviously, that's their decision. And the people that are making that are thinking that it's in their best interest. I just don't know how much input they're getting from a voice of someone with a person with a disability. Laurie: One other point is it expands the talent pool that employers can recruit from. They're not limited to just their area or just the people who can come into the office, but it really broadens that talent pool and once again, enables them to bring a more diverse workforce into their organization. Ronza: So I'll say that, you know, in the government workforce, we have seen this switch, right? So prior to the pandemic, there were some people that were working remotely, but not very many because the perception was, no, no, no, we can't do this work remote in a remote way. We need to serve the people, the public, etc. And then the pandemic happened and bam, we have to work remotely in order to serve the people. And then everything was moving along. And I think that was really the renaissance for the disability community and government. And then government started shifting back to more in-person presence and more and more in-person presence. And the thought was, well, if you need to work from home, you can request a reasonable accommodation. And while that's true, it can be very isolating. If we're not building work, community. In a way that's hybrid or in a way that is inclusive of those that are working from home for whatever reason, then we are excluding those people. And so giving them the ability to work from home as a reasonable accommodation, if that's the solution, it can't be the only solution because what it does is it creates a different expectation and standard and isolation. And all these people with a disability are over here and everyone else is over here. And so I think employers need to really be thinking mindfully about what a hybrid work environment looks like and how to ensure inclusion for those who, for whatever reason, are working from home all or much of the time. And we can do it. We have done it. We've been very creative in the last five years. But I think we're just not thinking about it. We're letting the economic and other considerations and, you know, the ease. My favorite phrase that people give me was, well, we need people in the building because of line of sight supervision. And I always say, well, I'm a manager and I'm blind. So line of sight supervision doesn't do anything for me. Are you saying I'm not as good of a manager as you? And then, you know, they don't mean it that way, but that's how it comes off. And that's really how they're thinking. They're thinking they have to be in my space for me to effectively manage them, which we have proven doesn't have to be the case. In fact, we can be very effective as if not more productive with people in their own comfortable environment. Kevin: Ronza, you expressed that better than I could ever have done. I think that's a really important aspect of remote work. It could not put anyone at a disadvantage or be isolating. With the last couple minutes we have left, I'd just like to hear from everyone about where we have come from and what you'd like to see in the future, some progress we've made, and where you think we still need to improve. So Nick, if you'd like to talk a little bit about that. Nicholas: Yeah, I'll say I can recall an instance about 12, 13 years ago, maybe, where I was interested in a summer internship with a law firm. And I noticed they had a diversity recruitment event, something like that. And they were looking for women and ethnically diverse or persons of color to attend. And I recall thinking to myself, well, I am a white male, but if they're looking for diverse candidates, I would assume that they would be interested in a person with a disability. So I emailed the firm's event organizer and I sort of posed the question of, can I attend? And of course the answer was yes, but it really goes to show where we were 12 to 14 years ago. And we may still be there in terms of what diversity is and or how law firms specifically view diversity. It may just be that they focus on these two categories. And that is a fine thing. It's just not an inclusive thing. I sort of commend the efforts. And I think we've gone farther than that over the past 12 to 14 years. But if we want to create an inclusive industry, doing so in an exclusive manner is not going to get us there. And I would encourage firms in their recruitment efforts to think about all of the minority groups or underrepresented groups in this industry and make intentional efforts to be inclusive for all of them. Kevin: Thank you, Nick. Ronza, would you like to add? Ronza: Sure, I 100% agree. I think that it's not just in the legal profession, it's in a lot of professions that the focus on diversity has been on race and gender and, you know, the SOGI areas. And there hasn't been as much advancement with disability, but this is certainly an opportunity. The American Bar Association currently has a campaign called the Be Counted Campaign for lawyers specifically and those in the legal profession who do have disabilities who can, you know, confidentially essentially be counted as a member of the disability community so that we can get a better number of who in fact is in this profession because we know it's not half a percent. You know, we know it's more than that. And we need to eliminate the stigma in this and every profession for those that are comfortable, psychologically safe, identifying as people with disabilities, even if it's anonymized, to be able to do so. I am optimistic in terms of where we're headed. I think the effort that we've put forward as a disability community and nothing about us without us has really tremendously borne some fruit. And I think though there's work to do, I think we've come a long way. I think that the ADA regulations on Title II that were the Department of Justice released are going to be a game changer. I think that when the Title III regulations are released, whenever that is, it's going to be another huge game changer. I think that Section 508 of the Rehabilitation Act is very, very much in need of a refresh and some updates. And when that happens, and I know there's some effort in Congress already, that's going to help. And I think some of the fundamental civil rights laws and protections in states and in the federal sector are going to continue this progress. But those are just the underpinning. It's the attitudes of people. It's listening to a podcast like this and learning about people you didn't think about before or aspects you didn't think about before, and then becoming a good ally to those communities. If you are in the community and feel comfortable speaking up with your lived experience, that's going to be a game changer too. 25% of this country. That's who we are. And so everybody knows somebody. Everybody has a family member who is a person with a disability who've experienced some of these challenges. Listen to their stories. Ask about their stories. Educate yourself and become a good ally so that the next generation has an easier time. That's what I'm excited about because I see it happening much more often. And I think it will continue to happen in this generation and the ones to come. Kevin: Thank you so much. Laurie, how about you? what do you see in the future? Laurie: Well, I think these are all such great points. And I'm going to go back to Nick's example. You know, I think historically DE&I has included, you know, a lot of minority groups except the disability community. And more and more, as I'm speaking with, you know, our enterprise customers, they're starting to add accessibility into that equation and really target disability hiring and bringing disabled talent into their pipelines. A lot of organizations are creating neurodiversity centers of excellence and neurodiversity hiring programs to specifically target that part of the population. So like Ronza said, I'm encouraged and I'm seeing this become a much higher priority for our enterprise customers. And again, to echo what she just said, I think the more we talk about it, the more we have podcasts and people listen to podcasts, the more comfortable and confident we get. I think we don't talk about accessibility because we're uncomfortable talking about disability, because people are afraid they're going to say the wrong thing. And at some point, we are all going to say the wrong thing, and that's okay. It's a learning opportunity for all of us. So again, thank you for the opportunity for us to come together today and talk about this really, really important topic. Kevin: Well, I just want to say very heartfelt thanks to all of you, Laurie, Ronza, and Nick for all of your insights today, for your time, and for the lessons you've shared with us. I think people will really get a lot out of this. And for our listeners, thank you for joining us for Inclusivity Included, and please stay tuned for future episodes. Thanks, everyone. Outro: Inclusivity Included is a Reed Smith production. Our producers are Ali McCardell and Shannon Ryan. You can find our podcasts on Spotify, Apple Podcasts, Google Podcasts, reedsmith.com, and our social media accounts. Disclaimer: This podcast is provided for educational purposes. It does not constitute legal advice and is not intended to establish an attorney-client relationship, nor is it intended to suggest or establish standards of care applicable to particular lawyers in any given situation. Prior results do not guarantee a similar outcome. Any views, opinions, or comments made by any external guest speaker are not to be attributed to Reed Smith LLP or its individual lawyers. All rights reserved. Transcript is auto-generated.
Stacey is a civil engineer and a General Superintendent with Consigli's Portland office. In her role, Stacey manages the construction of large-scale commercial projects, with a focus on life science and pharmaceutical facilities. She earned a B.S. in civil and environmental engineering at UMaine and earned her MBA from Rensselaer Polytechnic Institute. A video of Stacey talking about being in the construction industry can be found here.This conversation was recorded in October 2024 ~~~~~The Maine Science Podcast is a production of the Maine Discovery Museum. It is recorded at Discovery Studios, at the Maine Discovery Museum, in Bangor, ME. The Maine Science Podcast is hosted and executive produced by Kate Dickerson; edited and produced by Scott Loiselle.The Discover Maine theme was composed and performed by Nick Parker.To support our work: https://www.mainediscoverymuseum.org/donate. Find us online:Maine Discovery MuseumMaine Discovery Museum on social media: Facebook InstagramMaine Science Festival on social media: Facebook Twitter InstagramMaine Science Podcast on social media: Facebook Twitter Instagram © 2024 Maine Discovery Museum
Waking Dreams Media helps Tech and Life Science companies turn their complex products into simple videos that customers and investors love. Then, they help them scale their online audience with content. Connect with Luke
The 2025 Wisconsin Agricultural Outlook Forum is set to bring fresh insights and dynamic conversations to Wisconsin's agricultural community. Hosted by the Renk Agribusiness Institute, the forum will take place on Tuesday, January 21, from 10:00 a.m. to 4:00 p.m. in Varsity Hall at Union South, UW–Madison. The event's theme, “Wisconsin Agriculture Under a Second Trump Presidency,” reflects timely discussions about the changing landscape of agriculture under new leadership. “This year, we're stepping away from traditional formats,” said Dr. Paul Mitchell, coordinator of the event. “Attendees can expect engaging conversations, not just charts and graphs.” The morning kicks off with expert presentations on Wisconsin's farm economy. Specialists from UW–Madison College of Agricultural and Life Sciences, UW–Madison Division of Extension, and industry leaders will discuss the state of dairy, grain, livestock, and farm income. Key insights from The Contribution of Agriculture to the Wisconsin Economy report will also be shared. The afternoon session transitions to interactive panels focused on macro and local agricultural impacts. Topics include: Trade and Tariffs: How trade policies could evolve. Labor and Deportations: Challenges for agricultural labor. Bioenergy Policies and Conservation Programs: Potential policy changes. The Next Farm Bill: What might lie ahead. “Instead of lengthy presentations, we're prioritizing dialogue between panelists and the audience,” added Dr. Mitchell. “We want everyone to leave with a deeper understanding of what's coming and how to prepare.” See omnystudio.com/listener for privacy information.
The start of summer 2025 will mark the end of Michael Parrella's near decade as dean of the University of Idaho's College of Agricultural and Life Sciences. Parrella also spent nearly 30 years as a key agricultural figure in California at UC Davis and UC Riverside.As retirement nears, Parrella said he's optimistic that research at the university level and through Redox and others in the private sector will help growers do more with less.“Ultimately what we really want to do is grow a healthy plant and use less traditional fertilizer,” Parrella said. “Less nitrogen and less potassium. I think the work with micronutrients is going to enable us to do that. That's a huge part of dealing with sustainability of agriculture and healthy soils moving forward.”He said he'd like his time at the University of Idaho to be remembered for two primary areas: hiring the best early career faculty possible, supporting the existing faculty and having updated facilities for them to carry out effective work.
The Wall Street Journal recently reported that China is aggressively targeting tech talent with lucrative job offers, offering triple the pay for positions in the chip-making industry, sparking concerns in the West. This trend isn't unique to tech; similar tactics have been used in the life sciences. For instance, a Harvard law professor was charged in 2020 for funneling information to China, while in 2019, the Department of Justice settled with two researchers over undisclosed Chinese grants. More recently, in September 2024, the University of Albany settled for failing to disclose Chinese funding.China's strategy, part of its broader push for scientific development, economic prosperity, and national security, involves offering competitive salaries and recruiting top talent in fields like machine learning, autonomous driving, and robotics. This initiative, which mirrors past efforts such as the "Thousand Talents Program," has raised concerns globally, particularly in the U.S. and EU, with fears that top researchers may be lured away to China, potentially impacting industries like life sciences and semiconductors.The potential exodus of talent could create significant challenges for drug and device companies, particularly if leading scientists decide to work for Chinese companies. China is also reportedly targeting German companies in the chip industry, adding to the concerns. This situation highlights the growing geopolitical tension between the West and China, with China taking aggressive steps to secure international scientific talent amidst restrictions on its investments. How will this impact global research and innovation? Have you seen similar trends in your field? Let us know your thoughts!Support the show
Today's guest is Vickram Srivastava, Head of North American Supply Chain at SUN Pharma. SUN Pharma is a global pharmaceutical corporation based in Mumbai, India. The company produces and distributes pharmaceutical formulations and active pharmaceutical ingredients (APIs) to over 100 countries worldwide. Vickram joins us on today's program to share his expertise on the critical challenges facing the sector, particularly in the wake of global disruptions and increasing regulatory demands. This episode is sponsored by Arkestro. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1.
Mike回來啦，這集Mike跟若晴各自挑了一些新聞來跟大家分享，來聽聽看這次聊的有什麼有趣的吧！ 連結： RFK and Vivek: https://endpts.com/what-is-the-future-of-the-trump-admins-pharmaceutical-policies/ Recursion's Facebook: https://endpts.com/ai-focused-biotech-recursion-underwhelms-with-first-phase-2-readout/ Howard Chang to be Amgen's CSO: https://endpts.com/amgen-names-geneticist-and-biotech-founder-to-chief-science-role/ 節目內容： Mike回歸第一次錄音就出包 若晴開會順便去巡田水遇到聽眾 德州烤肉牛肋獨走整個岔題 竟然聊起12強 可能的新部長？ 墓仔埔也敢去 Amgen新CSO Recursion近期的臨床結果 針對腫瘤開發藥物的AI新策略 BioNemo的開源 整個開聊AI起來 -- Hosting provided by SoundOn
On this episode Justin records live at HLTH 2024 in Las Vegas. Stay tuned for the next few weeks to hear all his guests. This week tune in to hear Tony Nunes, Senior Manager, Healthcare & Life Sciences, AMD and Nick Patel, MD, Founder & CEO, Stealth Consulting. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
I am super excited for today's episode as I have special guest Dr Harriet Axbey on the show. Harriet Axbey is an autistic early career researcher at Swansea University. She is a research assistant on the “Autism from Menstruation to Menopause” Wellcome Trust Funded project within the Faculty of Medicine, Health, and Life Science. This project aims to look at the reproductive health experiences of autistic people with wombs across the lifespan.Harriets areas of expertise include:AutismNeurodivergenceNeurodiversityDiffusion ChainsUniversity AccessibilityHarriet is on the show today to share more about her recent book that's been published which is called: University: The Autistic Guide. This informative and friendly handbook is a guide to starting university for autistic young people, covering the entire process from applying, packing and financial admin to mental health support, dealing with burnout, finding your people and experiencing new opportunities. Harriet Axbey (@axbey) / XJonathan Raiseborough ✏✨ (@jo_raiseborough) / XHome | portfolio (jonathanraiseborough.wixsite.com)University: The Autistic Guide: Everything You Need to Survive and Thrive - Pavilion Publishing (pavpub.com)Understanding Others in a Neurodiverse World: A Radical Perspective on Communication and Shared Meaning - Pavilion Publishing (pavpub.com)University – The Autistic Guide: Everything You Need to Survive and Thrive: Amazon.co.uk: Harriet Axbey: 9781803882543: BooksMy Brother Tom Has Superpowers : Axbey, Harriet: Amazon.co.uk: BooksMy Brother Tom Has SuperpowersHarriet Axbey | YouCaxton PublicationsFollow Harriet on Blue Sky: https://bsky.app/profile/draxbey.bsky.social
Susun Weed answers 90 minutes of herbal health questions followed by a 30 minute interview with Teacher of science Gwen McPhail. Gwen "J. Stanion" McPhail was a National Board Certified teacher of science and taught a diverse course load from Food Science to Physics and from 7th grade Life Science to High School Livestock Production for 31 years. She retired to spend more time with her family on the farm and to have more time to be involved in her community. Gwen served on her local County Planning Commission and continues to serve on the board of a small agricultural non-profit. She spent three years during and after Covid to prepare and market her manuscript for "My Place Among Them". She continues to support the preservation of family farms in America, the practice of sourcing food locally and eating healthy.... Gwen believe in her mother's saying... "Pay your farmer, or you'll end up paying your doctor." Gwen McPhail's latest work is an opportunity to reflect on our past and present, to draw from the well of history and uncover life lessons that resonate more profoundly than ever in today's world. This literary time machine, "My Place Among Them," guides us through the annals of history and offers invaluable insights on resilience, cultural understanding, and the intricate workings of politics and bureaucracy.
Today's guest is Kimberly Powell, Vice President of Healthcare and Life Sciences at NVIDIA. Kimberly joins us to discuss how AI is reshaping the healthcare landscape. As generative AI adoption accelerates, Kimberly shares her insights on the major challenges the healthcare industry faces, particularly in terms of technology infrastructure. Together, we explore the critical need for hybrid strategies that blend on-premise and cloud computing, enabling real-time data processing for medical imaging, clinical operations, and more. Kimberly emphasizes the importance of developing infrastructure capable of supporting these advanced AI applications to improve patient care and operational efficiency. To discover more AI use cases, best practice guides, white papers, frameworks, and more, join Emerj Plus at emerj.com/p1.
Whether its found in nature or composed by chemists a sweetener undergoes the same evaluations, according to Corey Scott, PhD, Principal Nutritionist, Cargill. Dr. Scott explains to co-hosts Anne Chappelle, PhD, and David Faulkner, PhD, how all sweeteners must be able to replace multiple properties inherit in sugar, such as taste, nutritional content, and binding properties.About the GuestCorey Scott, PhD, is a Principal Nutrition Scientist with Cargill in Minneapolis, Minnesota, where he leads global nutritional research on sweeteners and carbohydrates. Prior to this role, he was Global Nutrition Manager for Lipid Nutrition BV in the Netherlands, focusing on clinical research involving novel lipids for early life nutrition, weight management, and diabetes. Dr. Scott has also worked for General Mills in Golden Valley, Minnesota, as a nutrition scientist at The Bell Institute of Health and Nutrition. He currently serves as a steering team member and work package leader for Project SWEET (a five-year EU Consortium project evaluating sweeteners). He is the Chair of the Institute for the Advancement of Food and Nutrition Sciences Low- and Non-caloric Sweetener Committee, Chair of the North Carolina Agricultural and Life Sciences at North Carolina State University Technical Advisory and Finance Committee, and an industry advisor for the University and Industry Consortium/Foundation for Food and Agriculture Research Sally Rockey Fellowship. Dr. Scott holds a doctorate degree in food science and nutrition from Ohio State University, a master's degree in chemistry from North Carolina A&T State University, and a bachelor's degree in chemistry from the University of North Carolina at Chapel Hill. Send SOT thoughts on the episodes, ideas for future topics, and more.
Today we're diving deep into the intricate world of workplace wellness and employee well-being with our special guest, Prudence Pitter. Prudence, the Global Head of HR for Amazon Web Services (AWS) overseeing sectors like Auto Manufacturing, Healthcare, and Life Sciences, brings over 20 years of rich HR experience to the table.In this episode, we'll explore:The profound impact of personal connections in the workplaceThe significance of genuine concern from leadersThe power of vulnerability in building strong teamsChallenges of mental health, both in our personal lives and within the organizational framework Effective strategies like gratitude practices, employee assistance programs, and innovative wellness initiativesJoin us as Prudence shares her personal journey of managing her son's mental health challenges and how it shaped her focus on creating supportive work environments. We'll also delve into successful wellness practices at AWS, from no-meeting days to running clubs, and discuss how leaders can lead by example to foster a culture of well-being and resilience.Prudence Pitter is a CHRO, Global Keynote Speaker, Board Member, and experienced business executive with over two and a half decades of progressive Human Resource leadership experience across several industries. She has worked extensively with Boards of Directors, leadership teams, and various business leaders in optimizing the culture, morale and productivity of their workforces. In addition, she has successfully and personally managed mergers and acquisitions, openings and closings, union negotiations, building and relocating corporate headquarters operations, associate communications, public and community relations as well as building and restructuring HR teams.Connect with Andy Storch here:WebsiteLinkedInJoin us in the Talent Development Think Tank Community!Connect with Prudence Pitter:LinkedInWebsite
What if the biggest challenge of our time isn't living longer, but living better? In this episode, we're tackling one of humanity's greatest accomplishments—and perhaps its most overlooked challenge: longevity. As more people live past 100, our systems—healthcare, finance, career planning, and even our cultural perceptions of aging—need a fundamental overhaul. We're joined by Dr. Andrew Scott, author of The Longevity Imperative, and Vijay Pande a16z's Bio & Health general partner, to explore how a shift from “sick care” to “health care” could transform our lives. Together, we discuss the implications of longer lifespans, from the individual choices that can improve our healthspans to the economic and societal shifts required to sustain a healthier, more productive aging society. Join us as we reimagine the future of aging, where living to 100 can be more than survival—it can be a life well-lived. Resources: Find Andrew on X: https://x.com/profandrewscott?lang=enFind Vijay on X: https://x.com/vijaypandeLearn more about The Longevity Imperative:https://profandrewjscott.com/the-longevity-imperative/ Stay Updated: Let us know what you think: https://ratethispodcast.com/a16zFind a16z on Twitter: https://twitter.com/a16zFind a16z on LinkedIn: https://www.linkedin.com/company/a16zSubscribe on your favorite podcast app: https://a16z.simplecast.com/Follow our host: https://twitter.com/stephsmithioPlease note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
© 2020-2025 Ivy Podcast Discovery LLC
